NEUPOGEN 48MU / 0.5ml injectible solution medication leaflet

L03AA02 • filgrastim (G-CSF) • Antineoplastic and immunomodulating agents | Immunostimulants | Colony stimulating factors

Filgrastim is a medication used to stimulate the production of white blood cells, especially after chemotherapy or bone marrow transplant. This medicine helps the body fight infections more effectively when the immune system is weakened. Filgrastim is recommended for patients at increased risk of infections due to a low number of neutrophils, an important type of white blood cell.

Filgrastim is usually administered by subcutaneous or intravenous injection under medical supervision. The dose and duration of treatment are determined by the doctor based on each patient's needs and response to therapy. It is important to follow your doctor's instructions carefully to achieve the best results.

Common side effects of filgrastim may include bone or muscle pain, redness or swelling at the injection site, headache, or fatigue. In rare cases, more serious reactions may occur, such as difficulty breathing, fever, or severe allergic reactions. If you notice any unusual symptoms, contact your doctor immediately.

Filgrastim is an essential medicine for supporting the immune system during cancer treatments or after transplant. Careful monitoring and communication with your medical team are important for the safety and effectiveness of the treatment. Inform your doctor about any other medications or supplements you are taking to avoid unwanted interactions.